Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic Mesenchymal Stem Cells in End-stage Heart Failure with LVAD
NCT01759212Phase 3Terminated
- Sponsor
- AHEPA University Hospital
- Start
- Oct 2012
- Primary completion
- Jul 2022
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of MSV alogénicas in ischemic cardiomyopathy (ICM), heart failure (HF), sponsored by AHEPA University Hospital. Started Oct 2012; status: terminated.
02
Drugs
MSV alogénicas
03
Conditions
ischemic cardiomyopathy (ICM)heart failure (HF)
Beyond the preview
Go deeper on NCT01759212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01759212.